Form 4: Illumina Director Susan Siegel Receives Stock Grant

Illumina, Inc. director Susan E. Siegel was granted 2,072 restricted stock units as part of her director compensation.

Summary

• Director Susan E. Siegel acquired 2,072 shares of Illumina, Inc. (ILMN) common stock via a restricted stock unit (RSU) grant.
• The transaction occurred on May 21, 2026, at a valuation of $144.83 per share.
• Following this transaction, Siegel holds 16,535 shares directly and maintains an indirect interest in 4,006 shares through the Reed-Siegel Revocable Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting of the RSU award is contingent upon continued service as a director.

Future Outlook

The RSU award vests on the earlier of the one-year anniversary of the grant or the date immediately preceding the next annual stockholders' meeting, subject to continued service.

Industry Context

StockSavvy.ai notes that equity grants for board members are standard corporate governance practice to ensure long-term alignment between leadership and shareholder interests in the biotechnology sector.

Comparison to Industry Standards

• The grant structure is consistent with standard director compensation packages for large-cap life sciences companies.
• Vesting schedules tied to annual meetings are common practice among S&P 500 constituents.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the 2,072 restricted stock units in 2027.

Key Dates

Keywords

Illumina, ILMN, Director Compensation, Insider Transaction, Form 4, Equity Grant